Goldman Sachs Group Inc Novo Nordisk A S Call Options Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $6.75 Million - $8.25 Million	-56,700 Reduced 32.93%	115,500 $13.8 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $6.41 Million - $7.67 Million	52,200 Added 43.5%	172,200 $24.6 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $46.1 Million - $61.4 Million	-451,800 Reduced 79.01%	120,000 $15.4 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $52 Million - $114 Million	571,800 New	571,800 $52 Million
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $4.22 Million - $5.33 Million	50,000 New	50,000 $4.8 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $200B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.